Hirsutism
19
0
0
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (19)
Prevalence of Hyperandrogenism in Type 1 Diabetes
Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
Evaluation of Eflornithine on Facial and Forearm Skin
Clinical Evaluation of Silk'n Glide for Face
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism
Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser
Database Study on Patients With PCOS
Bone Status and Insulin Resistance in Hirsutism
Photodynamic Therapy for Permanent Hair Removal
Enhanced Safety Aesthetic Laser System
Prospective Study of Patients With Hirsutism
Enhanced Safety Laser Hair Removal System